DL-dimyristoylphosphatidylcholine

DB11283ApprovedSmall molecule

A synthetic phospholipid used in liposomes and lipid bilayers for the study of biological membranes. It is used in commercial drug preparations to solubilize drugs for injection.

Mechanism: As a phospholipid, DL-dimyristoylphosphatidylcholine can form a micelle with a hydrophobic core to contain lipophilic drugs while maintaining a hyrophilic outer portion to allow increased solubility of the drug in the aqueous environment of the blood or gastrointestinal tract.
Curator reviewed · 1 reference
Primary indication: DL-dimyristoylphosphatidylcholine is not an active pharmaceutical agent and has no indication.Curator reviewed
Formula / weight: C₃₆H₇₂NO₈P · 677.945 g/mol (avg)
First approval: United States, 2010
Also known as: dimyristoyl phosphatidylcholine · dimyristoyl-phosphatidylcholine · Dimyristoylphosphatidylcholine · DMPC
Brand names: Abelcet

Resolves to

Compound

UNIIU86ZGC74V5CAS18656-38-7ChEMBLCHEMBL316257ChEBI241349

Clinical / RWD

RxNorm1362902

Structure

InChIKeyCITHEXJVPOWHKC-UHFFFAOYSA-NSMILESCCCCCCCCCCCCCC(=O)OCC(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCC

Targets

P02647APOA1

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Marketed productAcross 1 country and 1 labeller

10+ReferencesStructured and connected to the statements they support

Which drugs share a target with DL-dimyristoylphosphatidylcholine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account